Galmed Pharmaceuticals Ltd. (GLMD) › Capital ExpendituresGalmed Pharmaceuticals Ltd. (GLMD) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2012: $32.0K2013: $13.0K2014: $770.0K2015: $159.0K2016: $17.0K2017: $12.0K2018: $90.0K2019: $12.0K2020: $44.0K2021: $11.0K2022: $4.0K$4.0K2012Capital Expenditures (USD)2022Fiscal YearCapital ExpendituresChange YoY2022$4.0K-63.6%2021$11.0K-75.0%2020$44.0K+266.7%2019$12.0K-86.7%2018$90.0K+650.0%2017$12.0K-29.4%2016$17.0K-89.3%2015$159.0K-79.4%2014$770.0K+5823.1%2013$13.0K-59.4%2012$32.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share